Clinical study of remazolam toluenesulfonic acid for general anesthesia in elderly patients

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042904

Enrollment

Unknown

Registered

2021-01-31

Start date

2021-02-28

Completion date

Unknown

Last updated

2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia

Interventions

experimental group: remazolam toluenesulfonic acid

control group:propofol

Eligibility

Sex/Gender

All

Age

55 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients over 60 years old; 2. ASA I-II patients.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiovascular disease; 2. Patients with liver and kidney dysfunction; 3. Patients with preoperative cognitive impairment.

Design outcomes

Primary

Measure	Time frame
Success rate of sedation;	—

Secondary

Measure	Time frame
Anesthesia induction time;	—

Countries

China

Contacts

Public ContactZhimeng Zhang

Zhangjiajie People's Hospital

153889491@qq.com+86 13974408421

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026